Posts Tagged ‘studies’

Targacept Announces Initiation Of Phase 2 Studies Of TC-6987 In Asthma And Type 2 Diabetes
Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced the initiation of separate Phase 2 clinical studies of its product candidate TC-6987 in disorders characterized by inflammation, one in asthma and one in Type 2 diabetes. TC-6987 is a modulator of the alpha7 neuronal nicotinic receptor and was discovered by Targacept …

Read more on Medical News Today

Poverty a leading cause of Type 2 diabetes, studies say
According to new Canadian research, living in poverty can double and even triple the likelihood of developing Type 2 diabetes.

Read more on CTV.ca

Studies find Glaxo drug has heart risks
WASHINGTON — Two teams of researchers have produced powerful new evidence that the diabetes drug Avandia increases the risk of heart problems and strokes, renewing questions about the safety of the medication.

(AFX UK Focus) 2010-06-26 16:55 Roche says diabetes drug studies show good results
ZURICH, June 26 (Reuters) – Swiss drugmaker Roche’s experimental diabetes drug taspoglutide showed good results in a series of late-stage studies, the group said on Saturday, after the drug suffered a severe setback just recently. Roche launched a risk mitigation programme for the drug developed under license from French group Ipsen after hypersensitivity problems were seen in some patients …